Evidence map›Paper›PMID 38515853›Full record

ReviewFrontiers in pharmacology2024

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis.

Xueying Ding, Shujie Sun, Jinjin Zhang, Huifang Zhao, Fenglan Lun, Xuemin Liu, Yiwan Zhen, Jinping Dong, Jingliang Wu

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP).Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Xueying DingMedical College, Weifang University of Science and Technology, Weifang, China.
Shujie SunMedical College, Weifang University of Science and Technology, Weifang, China.
Jinjin ZhangMedical College, Weifang University of Science and Technology, Weifang, China.
Huifang ZhaoMedical College, Weifang University of Science and Technology, Weifang, China.
Fenglan LunMedical College, Weifang University of Science and Technology, Weifang, China.
Xuemin LiuMedical College, Weifang University of Science and Technology, Weifang, China.
Yiwan ZhenMedical College, Weifang University of Science and Technology, Weifang, China.
Jinping DongMedical College, Weifang University of Science and Technology, Weifang, China.
Jingliang WuMedical College, Weifang University of Science and Technology, Weifang, China.
Weifang University of Science and Technology · CNNational Taiwan University Hospital · TWShandong First Medical University · CNThomas University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney diseaseferric citratehyperphosphatemiairon deficiency anaemiameta

Identifiers

PMID38515853
PMCPMC10955115
OpenAlexW4392559396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.